A Study to Compare the Effectiveness of Allium Sativum 3X and Cholesterinum 3X in the Treatment of Patients with Dyslipidemia (Age 20 to 60 years)

A comparative study on effectivesness of Allium Sativum 3X and Cholesterinum 3X in reducing low density lipoprotein in the management of Dyslipidemia in the age group 20-60 years - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/106643

Enrollment

Registered

2026-03-20

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E780- Pure hypercholesterolemia

Interventions

Intervention1: ALLIUM SATIVUM: Allium sativum 3X is administered to group A orally 5 to 10 drops in aqua 2 times a day Control Intervention1: CHOLESTERINUM: Cholesternium 3X is administered to group B

Eligibility

Inclusion criteria

Inclusion criteria: LDL Cholesterol 100 to 190mg per dl Patients of age group between 20 to 60yrs Patients who are not taking any other medications for dyslipidemia

Exclusion criteria

Exclusion criteria: Pregnant and breast feeding females Patients with severe systemic illness Immunucompromised patients

Design outcomes

Primary

Measure	Time frame
To determine the changes in the serum LDL level before and after administration of Allium sativum 3X as compared to Cholesterinum 3X in the management of dyslipidemia in the age group 20-60 years.Timepoint: The total period of study will be one year duration and each patient will be reviewed at 4 weeks interval and followed for 6 months. Assessment is done by analysing serum LDL and serum HDL level by a fasting lipid profile ensure the most precise lipid assessment.	—

Measure

Time frame

To determine the changes in the serum LDL level before and after administration of Allium sativum 3X as compared to Cholesterinum 3X in the management of dyslipidemia in the age group 20-60 years.Timepoint: The total period of study will be one year duration and each patient will be reviewed at 4 weeks interval and followed for 6 months. Assessment is done by analysing serum LDL and serum HDL level by a fasting lipid profile ensure the most precise lipid assessment.

—

Secondary

Measure	Time frame
To determine the changes in serum HDL level and Triglyceride level before and after administration of Allium sativum 3X as compared to Cholesterinum 3X in the management of dyslipidemia in the age group 20-60 years.Timepoint: The total period of study will be one year duration and each patient will be reviewed at 4 weeks interval and followed for 6 months. Assessment is done by analysing serum LDL and serum HDL level by a fasting lipid profile ensure the most precise lipid assessment.	—

Measure

Time frame

To determine the changes in serum HDL level and Triglyceride level before and after administration of Allium sativum 3X as compared to Cholesterinum 3X in the management of dyslipidemia in the age group 20-60 years.Timepoint: The total period of study will be one year duration and each patient will be reviewed at 4 weeks interval and followed for 6 months. Assessment is done by analysing serum LDL and serum HDL level by a fasting lipid profile ensure the most precise lipid assessment.

—

Countries

India

Contacts

Public ContactDr Shreeja B

Government Homoeopathic Medical College,Iranimuttom,Thiruvananthapuram-695009

drsreelathas@gmail.com09447694037

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026